Clostridium difficile infection in liver transplant recipients: A retrospective study of rates, risk factors and outcomes

American Journal of Transplantation

Volumn 14, Issue 8, 2014, Pages 1901-1907

  Mittal, C ^a   Hassan, S ^a   Arshad, S ^a   Jeepalyam, S ^a   Bruni, S ^b   Miceli, M ^a   Jacobsen, G ^a   Abouljoud, M ^c   Bajjoka, I ^c   Ramesh, M ^a,b,c   Alangaden, G ^a,b,c  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Bacterial: Clostridium difficile; clinical research; hepatology; infection and infectious agents; infectious disease; intestinal disease: infectious; liver transplantation; practice

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ADULT; ALCOHOL LIVER DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLON RESECTION; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; CLOSTRIDIUM INFECTIONS; COMORBIDITY; DIARRHEA; END STAGE LIVER DISEASE; ENTEROPATHY; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; DIARRHEA; END STAGE LIVER DISEASE; FEMALE; HUMANS; INTESTINAL DISEASES; LENGTH OF STAY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MICHIGAN; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84904692546     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12798     Document Type: Article

References (18)

1. Ginsburg PM, Thuluvath PJ., Diarrhea in liver transplant recipients: Etiology and management. Liver Transpl 2005; 11: 881-890.
2. Albright JB, Bonatti H, Mendez J, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007; 20: 856-866.
3. Stelzmueller I, Goegele H, Biebl M, et al. Clostridium difficile colitis in solid organ transplantation-A single-center experience. Dig Dis Sci 2007; 52: 3231-3236.
4. Ali M, Ananthakrishnan AN, Ahmad S, et al. Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis. Liver Transpl 2012; 18: 972-978.
5. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-2441.
6. Kato H, Kita H, Karasawa T, et al. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 2001; 50: 720-727.
7. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210.
8. Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990; 336: 97-100.
9. Brecher SM, Novak-Weekley SM, Nagy E., Laboratory diagnosis of Clostridium difficile infections: There is light at the end of the colon. Clin Infect Dis 2013; 57: 1175-1181.
10. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307.
11. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.
12. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-145.
13. Boutros M, Al-Shaibi M, Chan G, et al. Clostridium difficile colitis: Increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation 2012; 93: 1051-1057.
14. Ananthakrishnan AN., Clostridium difficile infection: Epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011; 8: 17-26.
15. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-1703.
16. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection 2009 through 2011. JAMA Intern Med 2013; 173: 1359-1367.
17. Walker AS, Eyre DW, Wyllie DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 2013; 56: 1589-1600.
18. Johnson AP, Wilcox MH., Fidaxomicin: A new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 2012; 67: 2788-2792.